Last reviewed · How we verify
NCT03652402: EU-TRAIN
Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
trial testing kidney transplantation in Kidney Transplant Rejection in 558 participants. Completed in 28 October 2021.
28 October 2021
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 558 |
| Start date | 27 November 2018 |
| Primary completion | 28 October 2021 |
| Estimated completion | 28 October 2021 |
| Sites | 9 locations across France, Switzerland, Germany, Spain |
Drugs / interventions tested
- kidney transplantation
Conditions studied
- Kidney Transplant Rejection — all drugs for Kidney Transplant Rejection →
- Kidney Transplantation — all drugs for Kidney Transplantation →
- Risk Stratification — all drugs for Risk Stratification →
- Prognosis — all drugs for Prognosis →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
Adults 18 to 100, any sex, with Kidney Transplant Rejection or Kidney Transplantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Main objective: To design a precision risk stratification system that predicts individual risk of rejection
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
The transformative potential of artificial intelligence in solid organ transplantation.
Al Moussawy M, Lakkis ZS, Ansari ZA, Cherukuri AR, et al · · 2024 · cited 15× · PMID 38993779 · DOI 10.3389/frtra.2024.1361491 -
On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes.
Meneghini M, Perona A, Crespo E, Bemelman F, et al · · 2022 · cited 7× · PMID 36248818 · DOI 10.3389/fimmu.2022.924825 -
Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies.
Cortes Garcia E, Giarraputo A, Racapé M, Goutaudier V, et al · · 2024 · cited 1× · PMID 39050190 · DOI 10.3389/ti.2024.13043 -
A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation.
Kervella D, Casanova-Ferrer F, Kotton CN, Donadeu L, et al · · 2025 · PMID 40980655 · DOI 10.1016/j.ekir.2025.06.056
Verify or expand the search:
- PubMed search for NCT03652402
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Transplant Rejection
Currently open trials in the same condition.
- NCT07412470 — A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantati · Phase 2, PHASE3 · recruiting
- NCT07053462 — CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk · Phase 1, PHASE2 · recruiting
- NCT06564649 — PROACT Pilot Trial · active not recruiting
- NCT07006532 — Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab · NA · recruiting
- NCT07275541 — Platelet Aggregation in the Diagnosis of Acute Graft Rejection · recruiting
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03652402 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 5 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03652402.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing